Iceland· IS-EU/1/11/716/001-004

Eurartesim

A artenimol und piperaquin product containing piperaquine phosphate,dihydroartemisinin, registered in Iceland by Alfasigma S.p.A.. The same ATC class is registered in 9 of our 19 countries.

ATC P01BF05

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedEurartesimATCP01BF05REGISTER NO.IS-EU/1/11/716/001-004PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Artenimol und piperaquin is registered in 9 of 19 countries.

Countries holding a registration under ATC P01BF05 (artenimol und piperaquin), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 6 of them publish a price we can compare per daily dose

Artenimol und piperaquin · ATC P01BF05

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Piperaquine Phosphate,Dihydroartemisinin
Manufacturer
Alfasigma S.p.A.
Country
Iceland (IS)
ATC code
P01BF05
ATC class
Artenimol und Piperaquin
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9681d236-aa1f-4fee-b76e-de7fb13e5a49
GET /v1/drugs/9681d236-aa1f-4fee-b76e-de7fb13e5a49?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmuhúðuð tafla",
  "source": "lyfjastofnun",
  "atc_raw": "P01BF05",
  "marketed": false,
  "strength": "320 mg/40 mg",
  "ma_number": "EU/1/11/716/001-004",
  "substance": "Piperaquine Phosphate,Dihydroartemisinin",
  "other_info": "Ávísun lyfsins er bundin við sérfræðinga í smitsjúkdómum.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
  "legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
  "ma_issued_serial": "40843"
}

See everything about artenimol und piperaquin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.